Age and sex normalization of intestinal permeability measures for the improved assessment of enteropathy in infancy and early childhood: Results from the MAL-ED study by Kosek, Margaret N. et al.
eCommons@AKU 
Department of Paediatrics and Child Health Division of Woman and Child Health 
7-2017 
Age and sex normalization of intestinal permeability measures for 
the improved assessment of enteropathy in infancy and early 
childhood: Results from the MAL-ED study 
Margaret N. Kosek 
Johns Hopkins Bloomberg School of Public HealtJohns Hopkins University, Baltimore 
Gwenyth O. Lee 
Fogarty International Center/National Institutes of Health, Bethesda, MD 
Richard L. Guerrant 
University of Virginia, Charlottesville, VA 
Rashidul Haque 
ICDDR, b, Dhaka, Bangladesh 
Gagandeep Kang 
Christian Medical College, Vellore, India 
See next page for additional authors 
Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_women_childhealth_paediatr 
 Part of the Pediatrics Commons, and the Women's Health Commons 
Recommended Citation 
Kosek, M. N., Lee, G. O., Guerrant, R. L., Haque, R., Kang, G., Ahmed, T., Bessong, P., Ali, S., Qureshi, S., Zaidi, 
A. (2017). Age and sex normalization of intestinal permeability measures for the improved assessment of 
enteropathy in infancy and early childhood: Results from the MAL-ED study. Journal of Pediatric 
Gastroenterology and Nutrition, 65(1), 31-39. 
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_paediatr/318 
Authors 
Margaret N. Kosek, Gwenyth O. Lee, Richard L. Guerrant, Rashidul Haque, Gagandeep Kang, Tahmeed 
Ahmed, Pascal Bessong, Syed Asad Ali, Shahida Qureshi, and Anita K. M. Zaidi 
This article is available at eCommons@AKU: https://ecommons.aku.edu/
pakistan_fhs_mc_women_childhealth_paediatr/318 
D
ow
nloaded
from
https://journals.lw
w
.com
/jpgn
by
B
hD
M
f5eP
H
K
av1zE
oum
1tQ
fN
4a+kJLhE
ZgbsIH
o4X
M
i0hC
yw
C
X
1A
W
nY
Q
p/IlQ
rH
D
3l7ttZ9b/V
uLA
6eidoE
+gZA
o8zK
m
4h8io+w
V
V
JU
G
t7abR
sb6oD
A
Y
P
sg==
on
01/20/2020
Downloadedfromhttps://journals.lww.com/jpgnbyBhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3l7ttZ9b/VuLA6eidoE+gZAo8zKm4h8io+wVVJUGt7abRsb6oDAYPsg==on01/20/2020
 Copyright © ESPGHAN and NASPGHAN. All rights reserved.
Age and Sex Normalization of Intestinal Permeability
Measures for the Improved Assessment of Enteropathy in
Infancy and Early Childhood: Results From theMAL-ED Study
Margaret N. Kosek, yzGwenyth O. Lee, §Richard L. Guerrant, Rashidul Haque,
jjGagandeep Kang, Tahmeed Ahmed, Pascal Bessong, yyAsad Ali, zzEstomih Mduma,
Pablo Pen˜ataro Yori, §§William A. Faubion, Aldo A.M. Lima, jjjjMaribel Paredes Olortegui,
Carl Mason, jjSudhir Babji, yyyRavinder Singh, yyShahida Qureshi, zzzPeter S. Kosek,
Amidou Samie, zzJohn Pascal, Sanjaya Shrestha, yBenjamin J.J. McCormick,
yJessica C. Seidman, y§§§Dennis R. Lang, yyAnita Zaidi, Laura E. Caulfield,
and §§Michael Gottlieb, the MAL-ED Network
ABSTRACT
Objectives: The aim of the study was to describe changes in intestinal
permeability in early childhood in diverse epidemiologic settings.
Methods: In a birth cohort study, the lactulose:mannitol (L:M) test was
administered to 1980 children at 4 time points in the first 24 months of life in 8
countries. Data from the Brazil site with an incidence of diarrhea similar to that
seen in the United States and no growth faltering was used as an internal study
reference to derive age- and sex-specific z scores for mannitol and lactulose
recoveries and the L:M ratio.
Results: A total of 6602 tests demonstrated mannitol recovery, lactulose
recovery, and the L:M ratio were associated with country, sex, and age.
There was heterogeneity in the recovery of both probes between sites with
mean mannitol recovery ranging for 1.34% to 5.88%, lactulose recovery of
0.19% to 0.58%, and L:M ratios 0.10 to 0.17 in boys of 3 months of age
across different sites. We observed strong sex-specific differences in both
mannitol and lactulose recovery, with boys having higher recovery of both
probes. Alterations in intestinal barrier function increased in most sites from
3 to 9 months of age and plateaued or diminished from 9 to 15 months of age.
Conclusions: Alterations in recovery of the probes differ markedly in
different epidemiologic contexts in children living in the developing
world. The rate of change in the L:M-z ratio was most rapid and
consistently disparate from the reference standard in the period between
6 and 9 months of age, suggesting that this is a critical period of physiologic
impact of enteropathy in these populations.
Key Words: environmental enteropathy, intestinal permeability, lactulose,
mannitol, reference values
(JPGN 2017;65: 31–39)
I ntestinal permeability has been assessed and found to be alteredin many pathological states including inflammatory bowel dis-
ease, celiac disease, cirrhosis, sepsis, and in environmental entero-
pathy (1,2). Abnormalities in intestinal permeability have been
implicated as both a result of undernutrition and a cause of growth
failure in children living in poverty. Intestinal permeability can be
measured using polyethylene glycols of variable sizes (3), CrEDTA
What Is Known
 Intestinal permeability assessments using dual sugar
probe assays are commonly used to assess disease
activity in inflammatory bowel disease, celiac disease,
and environmental enteropathy.
 Abnormalities in intestinal permeability are common
in children living in poverty, likely the result ofmultiple
infections with enteropathogens and undernutrition.
What Is New
 There are important differences in the probe recov-
eries between boys and girls.
 Probe recoveries and the lactulose:mannitol ratio are
associated with age.
 A reference z score is created to allow for the evalu-
ation of results to a comparable age- and sex-specific
population.
 The performance of the test in disparate populations
demonstrated aberrant permeability of the probes
differed between populations, suggesting that
physiologic injury that results from environmental
enteropathy is heterogeneous.
See ‘‘Biomarkers of Environmental Enteric Dysfunction:
The Good, the Bad, and the Ugly’’ by Jimenez and Duggan
on page 4.
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(4), and saccharide probes (5), but for both safety and technical
simplicity saccharide probes are the most routinely used (6–8).
Saccharides used have included lactulose, mannitol, rhamnose,
sucralose, and mixtures of these. Probe sugars share the basic
characteristics of being passively absorbed from the gut, minimally
metabolized, and excreted in the urine in proportion to the admi-
nistered dose. In general, combined saccharide solutions include
smaller more permeable mannitol a monosaccharide with a
maximal radius of 0.38 nm, a molecular weight of 182 Da and a
polar surface area of 121 A˚ngstro¨m^2 and the larger disaccharide
lactulose with a molecular radius of 0.62 nm, a weight of 342 Da,
and a polar surface area of 190 A^2 (9). Findings have classically
been reported as the ratio of lactulose to mannitol, to compensate for
variability related to the subjects including transit time, intestinal
surface area, and urine flow that can alter the recovery of the probes.
Although transport of mannitol was previously described as
transcellular, new evidence supports the in vivo transport, similar to
other hydrophilic solutes, to occur principally via 2 distinct pores
formed by tight junction proteins including claudins and occludins
having diameters 0.5 and 1 nm (10). The relative density of the
different pore size concentrates the smaller pores at the villous tip
(11) so that decreased mannitol recovery primarily reflects damage
to the collective villous surface area, whereas lactulose recovery is
thought to reflect permeability to large molecules that is likely to be
concentrated in crypts (12).
The lactulose:mannitol (L:M) test has often been used to
relate the effect of nutrition or sanitation-based interventions to the
gastrointestinal health of children living in poverty (13–18), and
several reports have found the L:M ratio (or the recovery of
lactulose) to be associated with growth faltering among at-risk
infants (7,19,20). The L:M test is also used as an outcome measure
in intervention trials aiming to prevent or treat environmental
enteropathy and/or child undernutrition (21–23).
The Etiology, Risk Factors and Interactions of Enteric
Infections and Malnutrition and the Consequences for Child Health
and Development (MAL-ED) is a longitudinal investigation of the
inter-relationship of infectious disease morbidity and dietary
intakes as they affect child growth, cognitive development, and
vaccine efficacy. The study hypothesizes that compromised intes-
tinal barrier function is a key biological mediator of these relation-
ships (24,25). Using a unified protocol for surveillance and sample
collection (25), data from 8 cohorts of approximately 200 infants
each from diverse geographic locations was gathered (26–33).
Due to repeated sampling in early childhood when changes in
permeability are known to occur as the gut matures and becomes
less permeable to large molecules, we sought to derive an age-
standardized norm. Both age- and sex-specific distributions of
mannitol recovery, lactulose recovery, and the L:M ratio were,
however, observed across the study sites. Because of apparent age-
and sex-related trends in permeability that were independent of
environmental exposures, permeability measures were converted to
age- and sex-specific z scores, using the Brazil site as the internal
reference population for the cohort. This normalization of the L:M
ratio, the percent mannitol recovery, and percent lactulose recovery
is intended to provide reference values for a pediatric population for
the improved interpretation of intestinal permeability, in particular
in reference to the assessment of environmental enteropathy.
METHODS
Etiology, Risk Factors, and Interactions of
Enteric Infections and Malnutrition and the
Consequences for Child Health and
Development Enrollment and Surveillance
The overall design and objectives of the MAL-ED study are
presented elsewhere (34), as are descriptions of each site (26–33), and
the general methods for the assessment of permeability (35), mor-
bidity (25), and growth (36). The sites chosen represented both urban
and rural settings, and were located in Dhaka, Bangladesh (BGD);
Vellore, India (INV); Bhaktapur, Nepal (NEB); Naushero Feroze,
Pakistan (PKN); Fortaleza, Brazil (BRF); Loreto, Peru (PEL); Venda,
South Africa (SAV); and Haydom, Tanzania (TZH). Allowing for loss
to follow-up, 2145 newborns were enrolled who met following
inclusion criteria: <17 days old, born singleton, birth weight
>1500 g, no serious illness or congenital anomalies, mother at least
16 years of age, and plans to stay in the community for at least 6
months. Children were not actively screened by serology for celiac
disease. Written consent to participate was obtained at enrollment and
the procedures for the study were reviewed and approved at each site
and at collaborating institutions.
Children had stool samples taken upon detected episodes of
diarrhea, monthly to detect the presence of enteropathogens in the
first year of life and quarterly in the second year of life. Details of
these findings are published (37–40).
Etiology, Risk Factors, and Interactions of
Enteric Infections and Malnutrition and the
Consequences for Child Health and
Development Sample Collection Protocol
The MAL-ED protocol involved L:M testing of infants at 3,6,
9, and 15 months of age within a window of 14 days of the child’s
day of birth. Children, who were considered generally healthy on
the day of testing (eg, who had not vomited or had diarrhea that
day), were fasted for a minimum of 2 hours before, and 30 minutes
following the administration of the dual probe solution, with the
exception of breast milk which was permitted ad libitum. The
solution included 250 mg/mL of lactulose and 50 mg/mL of man-
nitol (1002 mOsm/L), at a dose of 2 mL/kg up to a maximum of
20 mL. Children were encouraged to void before solution admin-
istration, a urine collection bag (Fisher Scientific, Pittsburgh,
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PA, cat #22275347) was placed and changed as needed for the
following 5-hour period. Urine volume was measured following
voiding and 1 to 2 drops of chlorohexidine (2.35%; Sigma Aldrich,
St Louis, MO) was added, after which the samples were aliquoted
and stored on ice. Urine aliquots were stored at 708C before
testing.
Laboratory Protocols
Analytic protocols are available online as Supplemental
Digital Content 2, http://links.lww.com/MPG/A981.
Standardization of Results Between
Laboratories and Calculation of
Lactulose:Mannitol z Scores
Urinary concentrations of mannitol and lactulose and urine
volumes were used to calculate percent mannitol recovery (urine
concentration mannitol [mg/L]  urine volume [L]  100/total
mannitol dosed [mg]), percent lactulose recovery (urine concen-
tration lactulose [mg/L]  urine volume [L]  100/total lactulose
dosed [mg]), and the L:M ratio (% lactulose recovered/% mannitol
recovered).
Results were excluded for the following reasons: no mannitol
or lactulose peak was detected by the laboratory; the calculated
mannitol or lactulose excretion was >100%; the urine collection
time was significantly longer (>5.5 hours) or shorter (<4.5 hours)
than protocol; specific problems occurred during the L:M procedure
were noted (eg, difficulties with ingestion, urine spillage, or fecal
contamination of a portion of the urine collected during the 5-hour
period following administration).
When the L:M test was performed outside of the protocol
window (>14 days before or after the scheduled date), the results
were still included as long as they were within 30 days of the
scheduled date.
To standardize tests results across the laboratories, adjusted
results were calculated by multiplying each laboratory results by a
correction factor determined based on available quality control data.
Details of the standardization are provided in Supplemental Digital
Content 3, http://links.lww.com/MPG/A982.
For analyses, the percent lactulose excretion, percent man-
nitol excretion, and L:M ratios were examined by sex, age, and site.
Because consistent trends were noted by age and sex across sites,
observed values were transformed into z scores that could be
interpreted as a measure of relative permeability adjusting for these
factors. The BRF site had no deviation in anthropometry from
the WHO growth standards with a mean LAZ of 0 at 24 months of
age and was therefore chosen to represent what were expected to be
the least abnormal gut permeability values. Typical patterns of
progressive postnatal linear growth failure were seen in the remain-
ing 7 sites with LAZ ranging between 1.3 in Nepal to 2.7 in
Tanzania at 24 months. Therefore, the BRF data were used as the
internal MAL-ED reference.
Visual inspection of Q-Q plots and tests of normality
(Shapiro-Wilks test and tests of skewness and kurtosis) were used
to determine appropriate Box-Cox transformations of the BRF
percent mannitol excretion, percent lactulose excretion, and L:M
ratio estimated separately for each age and sex.
The same parameters from the Box-Cox transformation
taken for the BRF site were then applied to variables from each
other site, approximating normality, but preserving differential
patterns in each site. Each of the adjusted percent mannitol,
percent lactulose, and L:M ratio, after Box-Cox transformation,
were then scaled relative to the distribution of the BRF data (ie,
ðX  mBRF;age;sexÞ=dBRF;age;sex). Consequently, the z scores of the
BRF data at each age and both sexes is approximately a standard
normal distribution (ie, mean 0, standard deviation 1).
We then calculated confidence intervals for the 5th, 10th, 25th,
50th, 75th, 90th, and 95th percentiles of these distributions based on
both parametric and non-parametric methods. Because the number of
children in each category within the Brazil site was relatively small
(100 per combination of age and sex), extreme values could not be
transformed to z scores with precision. Therefore, we chose not
estimate exact z scores above the 90th percentile, but rather to indicate
all values above this cutoff categorically (90%).
In addition, binary variables (percent lactulose, and L:M
above or below the 90th percentile of the BRF site and percent
mannitol below the 10th percentile of the BRF site) were each
calculated. Sample calculations for Box-Cox transformations are
available online as Supplemental Digital Content 4, Values for
Box-Cox Transformations,http://links.lww.com/MPG/A983; Supple-
mental Digital Content 5, Mean (SD) used for Box-Cox Transform-
ations, http://links.lww.com/MPG/A984; and Supplemental Digital
Content 6, Conversion of %L, %M, and L:M results from Brazil to
age- and sex-specific z scores as reference, http://links.lww.com/
MPG/A985
RESULTS
Of a potential 8580 urine collections possible (4 per child for
2145 unique children enrolled in the study), 829 (9.7%) were not
completed because the child withdrew from the study before the
TABLE 1. Total results available
Total urine
samples collected
 Urine samples within 30
days of target
Urine samples
with L:M results
Urine with L:M results
after quality control
BGD 934 931 930 926 (99.1%)
BRF 800 797 790 757 (94.6%)
INV 931 926 917 914 (98.2%)
NEB 926 926 914 909 (98.2%)
PEL 1033 1028 1026 1,014 (98.2%)
PKN 1018 1002 841 835 (82.0%)
SAV 890 825 804 608 (68.3%)
TZH 929 912 863 639 (68.8%)
Total 7461 7347 7085 6,602 (88.5%)
BGD ¼ Dhaka, Bangladesh; BRF ¼ Fortaleza, Brazil; INV ¼ Vellore, India; L:M ¼ lactulose:mannitol; NEB ¼ Bhaktapur, Nepal; PKN ¼ Naushero
Feroze, Pakistan; PEL ¼ Loreto, Peru; SAV ¼ Venda, South Africa; TZH ¼ Haydom, Tanzania.
Urine collections where no urine was collected are not included.
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scheduled date, and 290 (3.4%) were not completed for other reasons.
Of the 7461 completed urine collections, 7347 (98.5%) occurred
within 30 days of the scheduled date, and 7047 (94.4%) occurred
within 14 days (Tables 1 and 2). A total of 7347 had laboratory
results available. Of the remainder, 61 did not have results due to
specific site or laboratory issues, and the remaining 144 lacked a
result because the sample quantity was not sufficient to run the test.
Of the 7260 urine collections completed with laboratory
results available, 581 were flagged during quality control checks.
The most common reason for flagging a result was that the reported
urine collection time was less than 4 and a half hours (n¼ 322),
followed by a reported urine collection time longer than 5 and a half
hours (n¼ 190). Fifty-eight results were flagged because no mannitol
peak was observed, 34 were flagged because no lactulose peak was
observed, and 9 results were flagged because either the calculated
percent mannitol recovery, or the calculated percent lactulose recov-
ery, was>100%. An additional 2 results where the dosage of the L:M
solution given to the child was not known, and 75 results that were not
flagged by quality control checks, but were collected>30 days before
or after the scheduled test date, were also excluded, leading to a final
total of 6602 results included in analysis.
Out of 2145 study participants, 1980 had at least 1 complete
L:M result available (run within 30 days of ideal date). One
hundred thirty-eight children had only 1 complete L:M test avail-
able, 245 had 2 complete L:M tests, 414 had 3 complete tests, and
1183 had 4 complete L:M tests available.
Mannitol and Lactulose Recovery
Across all sites and ages, the geometric mean adjusted
percent mannitol recovery was 2.1%, and the geometric mean
adjusted percent lactulose recovery was 0.28% (Fig. 1A and B).
Both percent mannitol and percent lactulose recoveries were high-
est in the youngest age group (percent mannitol¼ 2.1, 1.9, 1.8, and
1.8%, and percent lactulose¼ 0.28, 0.23, 0.20, and 0.18% at 3, 6, 9,
and 15 months of age, respectively).
Sex differences in percent mannitol and percent lactulose
recoveries were also observed. Percent mannitol and percent lac-
tulose recoveries were significantly higher in boys than in girls at all
ages, although this sex difference was less pronounced at older ages
(mannitol¼ 2.5% vs 1.8% at 3 months, 2.4% vs 1.5% at 6 months,
2.1% vs 1.5% at 9 months, and 2.0% vs 1.5% at 15 months of age;
lactulose¼ 0.31% vs 0.24% at 3 months, 0.27% vs 0.19% at 6
months, 0.23% vs 0.18% at 9 months, and 0.20% vs 0.17% at 15
months of age). These differences were due to urinary
concentrations of both lactulose and mannitol were higher in boys
than in girls (geometric means 2.22 mmol mannitol/L vs 1.77 mmol
mannitol/L and 0.66 mmol lactulose/L and 0.57 mmol lactulose/L);
and boys tended to produce greater volumes of urine during the 5-
hour urine collection test than girls (mean urine volumes of 63.5 vs
50.3 mL at 3 months, 52.3 vs 41.9 mL at 6 months, 49.2 vs 42.7 mL
at 9 months, and 54.0 vs 48.6 mL at 15 months).
Children in 4 sites (BGD, INV, NEB, and PEL) had percent
mannitol recoveries that were higher than that of BRF at most or all
TABLE 2. Total samples available by age
3 6 9 15 Overall
Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls
BGD 120 123 115 122 113 115 107 111 455 471
BRF 101 99 99 97 97 89 93 82 390 367
INV 105 125 102 128 105 124 102 123 414 500
NEB 124 109 125 106 123 104 119 99 491 418
PEL 152 126 144 124 133 113 124 98 553 461
PKN 111 102 102 109 109 106 100 96 422 413
SAV 81 77 68 70 74 67 88 83 311 297
TZH 86 74 78 84 80 80 81 76 325 314
Total 880 835 833 840 834 798 814 768 3361 3241
BGD ¼ Dhaka, Bangladesh; BRF ¼ Fortaleza, Brazil; INV ¼ Vellore,
India; NEB¼ Bhaktapur, Nepal; PKN¼ Naushero Feroze, Pakistan; PEL¼
Loreto, Peru; SAV ¼ Venda, South Africa; TZH ¼ Haydom, Tanzania.
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FIGURE 1. A–C, Adjusted % mannitol recovery, % lactulose recovery,
and lactulose:mannitol (L:M), by site. All results above the 99thpercentile
have been excluded for clarity (mannitol 99th percentile¼15.229,
lactulose 99th percentile¼2.084, L:M 99th percentile¼2.3388).
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ages, whereas children at 2 sites (TZH and SAV) had mannitol
percent mannitol recoveries that were similar to or below those from
BRF at most ages (Table 3 and Fig. 2A). In every site, the percent
lactulose recovery was relatively greater than that of BRF at almost
all combinations of age and sex (Table 4 and Fig. 2B). The mean z
scores for mannitol and lactulose recovery by site and age are shown
in Figure 3A and B.
Lactulose:Mannitol Ratio
The L:M ratio decreased with age in the reference site
(BRF) from 3 to 9 months and stabilized between 9 and 15
months of age (Table 5). In 3 sites (BGD, NEB, PKN), L:M
decreased with age, and in the other 4 sites, it increased with age
(INV, PEL) or remained roughly stable with age (SAV and
TZH). Overall, there was a trend of higher L:M ratios among
girls than boys, but this difference was not significant across
most age and sites.
Relative to BRF, children from most sites had L:M scores
that were similar at 3 months of age, but were elevated at 6, 9, and
15 months of age (Table 5), and differences between sites in L:M
ratios were generally more pronounced in boys than in girls
(Fig. 2C). Mean values of mannitol and lactulose recoveries
and the L:M ratio for children in BRF are shown for reference
(Supplemental Digital Content, Table 3, Conversion of %lactulose,
%mannitol, and L:M results to z scores, http://links.lww.com/MPG/
A985). The mean L:M z score by site and age is shown in Figure 3C.
DISCUSSION
The MAL-ED study provides a rich source of information on
intestinal permeability during early child as it is the largest study of the
L:M test ever conducted in young children, utilizing a common
protocol with strict quality assurance across 8 sites around the world.
Although intestinal permeability tests have been used for some time,
the failure of different groups to use a common dose of probes, urine
collection time, analytic methodology for the determination of analytes
in urine, and procedures for results reporting all lead to a constricted
capacity to interpret test results across study populations (41). This
study addresses these limitations to allow for a robust comparison of
intestinal permeability as measured by the lactulose mannitol assay
across 8 geographically and epidemiologically diverse sites.
A limitation of the study was the need to process samples in
different laboratories. We have previously reported on the improved
performance of LC-MS/MS as compared to HPLC-PAD, particularly
in the accurate quantification of lactulose (42). To address this limita-
tion, 40 standards representing a wide range of concentrations in urine
were used to standardize findings across platforms in the native matrix
with values measured in a reference LC-MS/MS laboratory. This
combined with the common administration and collection protocol
allows for the robust comparison of findings across sites. Another
limitation was the lack of testing for celiac disease in this study.
Although the condition is too rare to have influenced our conclusions,
they would have been an interesting comparator group from which to
derive a more complete understanding of the relative severity of
environmental enteropathy in these contexts.
Mannitol recoveries were the lowest in TZH, SAV, and PKN
and varied 3-fold in boys and 5-fold in girls between TZH and INV,
the site with the highest mannitol permeability at 3 months of age.
Although the relative differences between populations attenuated
somewhat with age, disparate trajectories were apparent, with NEB,
INV, and PEL showing larger mannitol recoveries at each time
point suggesting that villous integrity is greater in these epidemio-
logic contexts. In the setting of environmental enteropathy where
malabsorption is thought to have a role in suboptimal growth of
children, this suggests that the risk of malabsorption is hetero-
geneous in different high-risk and high-prevalence populations for
environmental enteropathy.
Lactulose recovery was the highest in INV and BGD and the
lowest in BRF and SAV. Differences in permeability to lactulose
across sites at different time points varied from 2- to 6-fold relative
to the reference population demonstrating significant and important
differences in the permeability of the gut to this larger probe across
these contexts.
The average L:M ratio was higher than the 0.02 seen in US
and European norms (43), it was lowest in BRF, highest in PEL,
PKN, and BGD, and generally decreased as children aged. The sex
differences present for each of the probes in turn were largely absent
in the L:M ratio, highlighting the difficulty in interpreting the ratio.
When considering the L:M ratio, 5 of 6 sites were elevated relative
to BRF, but interestingly, the probe driving this increase varied. In
NEB, although both mannitol and lactulose recoveries were elev-
ated relative to BRF, they were elevated to a similar degree, leading
to a similar L:M ratio between the 2 sites. In SAV and TZH, lower
mannitol excretion was the major driver of L:M, whereas in the
Southeast Asian sites and PEL, lactulose was the more important
determinant of the ratio similar to recent reports (44).
TABLE 3. Percent mannitol recovery-adjusted results by age, sex and
site (geometric means; P values based off t tests comparison of logged
concentrations)
3 Months 6 Months 9 Months 15 Months
BGD
Boys 2.86 2.45 2.87 4.04
Girls 2.61 2.41 2.23 2.98
P 0.4707 0.8752 0.0465 0.0057
BRF
Boys 1.90 2.07 1.75 1.33
Girls 0.80 0.82 0.91 1.01
P 0.0001 <0.0001 0.0003 0.0748
INV
Boys 6.75 5.71 5.92 6.67
Girls 4.64 3.66 4.63 4.75
P 0.0015 <0.0001 0.0411 0.0106
NEB
Boys 3.47 2.92 2.94 3.11
Girls 2.34 1.83 1.65 2.15
P 0.0003 0.0001 0.0001 0.0215
PEL
Boys 2.84 2.20 2.03 1.71
Girls 1.93 1.52 1.67 1.40
P 0.0014 0.0022 0.1593 0.3727
PKN
Boys 1.83 2.71 2.20 1.91
Girls 1.45 1.56 1.46 1.74
P 0.0979 0.0002 0.0094 0.5328
SAV
Boys 1.51 1.46 0.99 1.02
Girls 1.24 0.89 1.11 0.81
P 0.3394 0.0198 0.5569 0.2845
TZH
Boys 1.63 1.46 1.07 1.13
Girls 1.00 0.99 0.79 1.10
P 0.0039 0.0175 0.0797 0.4746
BGD ¼ Dhaka, Bangladesh; BRF ¼ Fortaleza, Brazil; INV ¼ Vellore,
India; NEB¼ Bhaktapur, Nepal; PKN¼ Naushero Feroze, Pakistan; PEL¼
Loreto, Peru; SAV ¼ Venda, South Africa; TZH ¼ Haydom, Tanzania.
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In the face of accepted interpretation of the test, the popu-
lations with the most abnormal mannitol and lactulose recoveries
relative to BRF in this study, or reference norms reported in the
literature (based on US or European populations) were not the
same, which was somewhat unexpected. Most published reports
using the lactulose mannitol probes to assess permeability report
only the lactulose mannitol ratio, or the lactulose recovery as
lactulose is thought to better represent the risk of intestinal
permeability to larger antigens, leading to intestinal and systemic
immune activation. This has been called into question, because
these small hydrophilic probes are 2 to 3 orders of magnitude
smaller than antigens, viruses, or bacteria and given their size and
physiochemical characteristics these probes are unlikely to be
transported by the same pathways as the other larger molecules
that permeate the intestine in certain pathologic states (9,45). Even
food antigens and small peptides are >600 Da, twice the size of
lactulose. Although permeability to the larger molecules is likely to
be accompanied by higher lactulose permeability, there is a large
range of increased permeability measured by the L:M assay that is
likely below the threshold of antigenic translocation and immune
activation. Our findings strongly suggest that adequate descrip-
tions of intestinal permeability following the administration of
lactulose and mannitol should describe the recovery of each probe
separately in addition to reporting the L:M ratio. Delinking the
recovery of lactulose and mannitol additionally suggests diverse
patterns of intestinal injury in different epidemiologic contexts,
and the recognition and characterization of this may be important
in both understanding the condition of environmental enteropathy
and guiding interventions to ameliorate it. Our group has also
recently described that individual pathogens, particularly with
Giardia (39) and Campylobacter (40), have important effects on
intestinal permeability as measured by the lactulose mannitol test
and clearly the difference distribution of enteropathogens may
contribute to this diversity.
One of the most notable findings of this large study is that there
are significant and sizable differences in intestinal permeability
associated with sex. Boys had higher urinary recovery of mannitol
than girls. Differences in mannitol recovery by sex were consistent,
significant, and highly reproducible across sites at the 4 ages assessed,
and consistently varied by >50% in most countries at most time
points. There are some reports of changes in intestinal permeability
by sex in the literature (11,46), but results have been conflicting on
this point (47), and have relatively small sample sizes. There are
different levels of estradiol and bioavailable estradiol in infants at 3
months of age, the age at which we did our first lactulose mannitol
assay (48). Estrogen receptor agonists have been shown to effect
claudin expression in the placenta, and in rabbit models estradiol
potentiates occluding expression and attenuated augmented
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FIGURE 2. A, Proportion of children at each site with % mannitol recovery below the 10th percentile for the Fortaleza, Brazil (BRF) site. Data are
presented for boys (left) and girls (right) separately. B, Proportion of children at each site with a% lactulose recovery above the 90th percentile for
the BRF site. Data are presented for boys (left) and girls (right) separately. C, Proportion of children at each site with an lactulose:mannitol (L:M)
ratio above the 90th percentile for the BRF site. Data are presented for boys (left) and girls (right) separately.
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permeability associated with acid exposure and oxidative irritants
(49). Recent in vitro work in intestinal injury models show estrogen
increases mucus production and decreases permeability following
oxidative stress. Although these findings are in animal and explant
systems, they do provide putative mechanisms that may explain our
findings. Furthermore, the consistency and degree of differences
warrant different normative values be reported by sex for the
improved interpretation of permeability assays.
Age-dependent changes in intestinal permeability are exten-
sively described in the first month of life and to a lesser extent in
elderly populations (50–53). More recently, detailed studies
suggest that there are modest but appreciable differences that
extend through early adulthood (11,54). We sought to derive an
age-specific reference to allow changes in permeability over early
life to be analyzed as a function of environmental and nutritional
exposures independent of age. When we determined that sex was
also an important determinant of probe recovery, we also normal-
ized by sex. The z scores derived from this study may have utility
for other groups evaluating permeability using similar protocols
for dosage and collection time. Although standardization of the
dosage is broadly understood, it is important to use standard
collection times as it will affect the probe percent recovery and
to a lesser extent the L:M ratio (55). The use of the z scores
developed here will enable the improved accuracy of the interpret-
ation of these tests in individual children and improve causal
inference in intervention studies where changes in permeability
are assessed as an outcome.
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Loreto, Peru; SAV ¼ Venda, South Africa; TZH ¼ Haydom, Tanzania.
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